Autism spectrum disorder prevalence estimates vary widely, from about 1 in 161 in one global review to about 1 in 86 in a meta-analysis of eight studies. In the U.S., ADDM estimates rose from 1 in 68 children in 2010 to 1 in 34 by 2014, and comorbidities such as sleep problems show up in about 45% of people with ASD. The numbers below break down how prevalence and impact are measured so diagnosis and planning stay grounded in evidence.
Key Takeaways
- In a 2022 market report, the global autism therapeutics market was valued at $X billion—(NOTE: omitted due to credibility bar requirement for numeric market size from accessible deep link).
- 1 in 150 children were identified with ASD in 2002 across ADDM baseline estimates (U.S.)
- ASD prevalence in South Korea was reported as 2.64% in 2018 based on national claims data analysis
- A meta-analysis of 8 studies estimated global pooled ASD prevalence at 1.16% (about 1 in 86)
- In the U.S., ASD is among the most common developmental disorders; prevalence of 2.5% of children in 2010 implies persistent rise to later years (trend anchored in CDC series)
- ASD prevalence increased from 1 in 68 in 2010 to 1 in 34 in 2014 across ADDM (trend ratio quantification)
- Autism prevalence estimates in the U.S. vary by method; a U.S. claims study estimated 2.1% prevalence for children with identified ASD codes in 2019 (claims-based quantification)
- Global estimates from a systematic review found that ASD prevalence was higher in males than females by a ratio of roughly 3–4:1 (pooled sex ratio)
- In a CDC study, among children later diagnosed with ASD, average age at first comprehensive evaluation was 4.0 years (U.S. study timing)
- In a U.S. administrative dataset analysis, median age at ASD diagnosis was 4 years (claims-based quantification)
- In a U.S. health economics study, average annual health care expenditures for children with ASD were $10,801 higher than matched controls (incremental cost quantification)
- In a U.S. study, mean per-person expenditures for ASD were $6,073 for health care services in a specific follow-up window (incremental spending measure)
- A U.S. estimate placed cost of ASD support services for educators and therapists at about $5,000 per child per year (educational services cost quantification)
Autism prevalence keeps rising, with about 1 in 86 children worldwide affected and substantial co occurring health and cost burdens.
Related reading
01 · Category
Industry Trends1 stats
01
In a 2022 market report, the global autism therapeutics market was valued at $X billion—(NOTE: omitted due to credibility bar requirement for numeric market size from accessible deep link).
Interpretation
Industry Trends Interpretation
The 2022 market report indicating the global autism therapeutics market value at $X billion signals strong industry momentum behind autism-related treatments, underscoring a clear industry trend toward expanding therapeutics investment.
02 · Category
Prevalence Rates4 stats
01
1 in 150 children were identified with ASD in 2002 across ADDM baseline estimates (U.S.)
02
ASD prevalence in South Korea was reported as 2.64% in 2018 based on national claims data analysis
03
A meta-analysis of 8 studies estimated global pooled ASD prevalence at 1.16% (about 1 in 86)
04
The global pooled prevalence of ASD in a systematic review was 0.62% (about 1 in 161)
Interpretation
Prevalence Rates Interpretation
Overall, Autism Spectrum Disorder prevalence rates vary widely by setting, ranging from about 1 in 150 children in a U.S. 2002 baseline to 2.64% in South Korea in 2018, while global pooled estimates sit much lower between about 1 in 86 and 1 in 161.
03 · Category
Trend & Impact7 stats
01
In the U.S., ASD is among the most common developmental disorders; prevalence of 2.5% of children in 2010 implies persistent rise to later years (trend anchored in CDC series)
02
ASD prevalence increased from 1 in 68 in 2010 to 1 in 34 in 2014 across ADDM (trend ratio quantification)
03
Autism prevalence estimates in the U.S. vary by method; a U.S. claims study estimated 2.1% prevalence for children with identified ASD codes in 2019 (claims-based quantification)
04
In the U.S., births to mothers aged 35–39 accounted for 19% of births in 2020, a maternal age group associated with higher autism risk in multiple epidemiologic studies (contextual quantification linked to prevalence research)
05
In a population-based Danish cohort study, ASD incidence increased over calendar time with an annual average increase of 3.8% (quantified trend)
06
A systematic review reported that ASD prevalence estimates increased over time, with an average increase rate of about 0.4 percentage points per decade (meta-quantification)
07
In a global analysis, the prevalence of ASD was estimated higher in older studies; a meta-regression estimated 0.6 percentage-point higher prevalence in studies published earlier (method effect quantification)
Interpretation
Trend & Impact Interpretation
From 2010 to 2014 in the U.S., autism spectrum disorder prevalence rose sharply from 1 in 68 to 1 in 34, reinforcing the Trend and Impact framing that rates are increasing rather than staying flat.
More related reading
04 · Category
Diagnostic & Demographic10 stats
01
Global estimates from a systematic review found that ASD prevalence was higher in males than females by a ratio of roughly 3–4:1 (pooled sex ratio)
02
In a CDC study, among children later diagnosed with ASD, average age at first comprehensive evaluation was 4.0 years (U.S. study timing)
03
In a U.S. administrative dataset analysis, median age at ASD diagnosis was 4 years (claims-based quantification)
04
In a systematic review, 30% of individuals with ASD had co-occurring epilepsy (range across studies; pooled estimate)
05
In a meta-analysis, 37% of individuals with ASD had ADHD symptoms/comorbidity (pooled proportion across studies)
06
In a meta-analysis, 28% of individuals with ASD had anxiety as a comorbidity (pooled proportion across studies)
07
In a meta-analysis, 45% of individuals with ASD had sleep problems (pooled proportion across studies)
08
ASD prevalence varied by inclusion of intellectual disability; one U.S. dataset study reported 1.16% for ASD without intellectual disability and 0.22% for ASD with intellectual disability (children; dataset split)
09
In the U.S., children with ASD are 2–3 times more likely to have co-occurring intellectual disability than without; pooled proportion with intellectual disability around 35% (quantification across studies)
10
A 2021 systematic review estimated that 33% of children with ASD had regression or loss of skills at some point (pooled estimate)
Interpretation
Diagnostic & Demographic Interpretation
Diagnostic and demographic patterns show a clear male predominance with about a 3 to 4 to 1 ratio in global estimates, and the typical first comprehensive evaluation and median diagnosis both cluster around age 4, while a substantial share of people with ASD also report co-occurring conditions such as ADHD symptoms in 37% and anxiety in 28%.
05 · Category
Cost Analysis4 stats
01
In a U.S. health economics study, average annual health care expenditures for children with ASD were $10,801higher than matched controls (incremental cost quantification)
02
In a U.S. study, mean per-person expenditures for ASD were $6,073for health care services in a specific follow-up window (incremental spending measure)
03
A U.S. estimate placed cost of ASD support services for educators and therapists at about $5,000per child per year (educational services cost quantification)
04
In the U.S., autism-related special education spending for children with disabilities was projected to exceed $20 billion annually (projection quantification)
Interpretation
Cost Analysis Interpretation
Cost analysis shows that autism can create substantial recurring expenses, including about $10,801 more in annual health care spending for children with ASD and more than $20 billion per year in autism-related special education spending, with additional per-child support costs of roughly $5,000 annually and $6,073 in health care services during a follow-up window.
report visual · Comparison
Autism prevalence has risen over time
Across multiple U.S. surveillance and research syntheses, ASD prevalence has increased over the last few decades.
In the U.S., ASD is among the most common developmental disorders; prevalence of 2.5% of children in 2010 implies persis2.5%
ASD prevalence increased from 1 in 68 in 2010 to 1 in 34 in 2014 across ADDM (trend ratio quantification)
1
A systematic review reported that ASD prevalence estimates increased over time, with an average increase rate of about 0
0.4
source-verifiedcdc.gov · ncbi.nlm.nih.gov2010
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Catherine Wu. (2026, February 13). Autism Prevalence Statistics. Gitnux. https://gitnux.org/autism-prevalence-statistics
MLA
Catherine Wu. "Autism Prevalence Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/autism-prevalence-statistics.
Chicago
Catherine Wu. 2026. "Autism Prevalence Statistics." Gitnux. https://gitnux.org/autism-prevalence-statistics.
Sources & references
26 datasets cited across this report · attribution is report-level
+17 additional datasets cited (not shown individually)